Apoptosis methods for PBMC lymphs

From: Kroeger, Jodi (KroegerJL@Moffitt.usf.edu)
Date: Mon Jan 04 1999 - 10:59:20 EST


Dear Colleagues,

Happy New Year!

I am posting a request for response for a user in my facility.
Specifically, she is trying to quantitatively assess the apoptotic response
of drug-treated patient PBMC lymphocytes (only) using an Annexin/PI kit.
She cultures the PBMCs for a specified amount of time with IL-2 to activate
them.  She then ficolls to remove the dead cells before Annexin staining.
When she brings them to me for flow analysis, we are seeing is a large
population of lymphs, a small population of monos, and a population of what
I believe to be non-lysed RBC's overlapping the apoptotic (various stages)
cells from the PBMCs.  This, of course, makes it difficult to distinguish
the apoptotic lymphs from the RBCs and apoptotic monos using light scatter.
I've suggested to this researcher that she find a common lymphocyte marker
(preferably read in the FL3 detector) so that we can more specifically gate
on only the lymphs.  She asked me to post a message on the Cytometry list to
see if there is anyone out there who is doing a similar assay who could give
her some suggestions.  So here it is.  Any and all replies will be greatly
appreciated.  Also, I would be grateful for any suggestions on optimal
acquisition techniques.

Thanks for your time,
Jodi

Jodi L. Kroeger
Coordinator, Flow Cytometry Core Facility
Moffitt Cancer Center & Research Institute
12902 Magnolia Drive
Tampa, Florida  33612
Office: (813) 979-6705
Lab:  (813) 972-8400 ext. 2005
Fax:  (813) 979-6700
kroegerjl@moffitt.usf.edu



This archive was generated by hypermail 2b29 : Wed Apr 03 2002 - 11:52:52 EST